InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Fox Christine Ann. Officer active across 1 company, notably Mereo BioPharma Group plc. In total, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €82k. History available since 21 June 2024. The latest transaction was filed on 12 September 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Christine Ann Fox is a declarant linked to Mereo BioPharma Group plc, where she is Chief Financial Officer. She has 4 filings in total, and among the 4 most recent filings we hold, they cover the period from 2024-06-25 to 2024-09-16, with EUR 81659 in sales and EUR 0 in purchases.